BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22994727)

  • 1. Direct costs of cervical cancer management in Morocco.
    Berraho M; Najdi A; Mathoulin-Pelissier S; Salamon R; Nejjari C
    Asian Pac J Cancer Prev; 2012; 13(7):3159-63. PubMed ID: 22994727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First data on direct costs of lung cancer management in Morocco.
    Tachfouti N; Belkacemi Y; Raherison C; Bekkali R; Benider A; Nejjari C
    Asian Pac J Cancer Prev; 2012; 13(4):1547-51. PubMed ID: 22799364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimated cost of managing invasive cervical cancer in Tunisia].
    Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the cost of cervical cancer at the National Institute of Oncology, Rabat.
    Cheikh A; El Majjaoui S; Ismaili N; Cheikh Z; Bouajaj J; Nejjari C; El Hassani A; Cherrah Y; Benjaafar N
    Pan Afr Med J; 2016; 23():209. PubMed ID: 27347298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco.
    Boutayeb S; Boutayeb A; Ahbeddou N; Boutayeb W; Ismail E; Tazi M; Errihani H
    Cost Eff Resour Alloc; 2010 Sep; 8():16. PubMed ID: 20828417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
    Lairson DR; Fu S; Chan W; Xu L; Shelal Z; Ramondetta L
    Gynecol Oncol; 2017 Apr; 145(1):108-113. PubMed ID: 28196673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of care for the initial management of cervical cancer in women with commercial insurance.
    Blanco M; Chen L; Melamed A; Tergas AI; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2021 Mar; 224(3):286.e1-286.e11. PubMed ID: 32818476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of invasive cervical cancer and direct costs associated with its management in Italy.
    Ricciardi A; Largeron N; Giorgi Rossi P; Raffaele M; Cohet C; Federici A; Palazzo F
    Tumori; 2009; 95(2):146-52. PubMed ID: 19579858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-specific healthcare costs of cervical cancer: estimates from a population-based study.
    Liu N; Mittmann N; Coyte PC; Hancock-Howard R; Seung SJ; Earle CC
    Am J Obstet Gynecol; 2016 May; 214(5):615.e1-615.e11. PubMed ID: 26627729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment costs of malignant cervical cancer in Poland in 2011-2012--the case of Silesian Voivodeship].
    Holecki T; Sobczyk K; Nawrocki S; Woźniak-Holecka J; Skrzypek M; Bocionek A
    Ginekol Pol; 2015 Nov; 86(11):849-55. PubMed ID: 26817317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of health-care costs for cervical uterine neoplasm].
    Sánchez-Román FR; de Jesús Carlos-Rivera F; Guzmán-Caniupan JA; Escudero-de Los Ríos P; Juárez-Pérez CA; Aguilar-Madrid G
    Rev Med Inst Mex Seguro Soc; 2012; 50(1):99-106. PubMed ID: 22768826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Invasive cervical cancer treatment costs in France].
    Arveux P; Bénard S; Bouée S; Lafuma A; Martin L; Cravello L; Rémy V; Breugelmans JG
    Bull Cancer; 2007 Feb; 94(2):219-24. PubMed ID: 17337390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
    Brown RE; Breugelmans JG; Theodoratou D; Bénard S
    Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil.
    Novaes HM; Itria A; Silva GA; Sartori AM; Rama CH; Soárez PC
    Clinics (Sao Paulo); 2015 Apr; 70(4):289-95. PubMed ID: 26017797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment.
    Helms LJ; Melnikow J
    Med Care; 1999 Jul; 37(7):652-61. PubMed ID: 10424636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-specific treatment costs for cervical cancer in the United Kingdom.
    Wolstenholme JL; Whynes DK
    Eur J Cancer; 1998 Nov; 34(12):1889-93. PubMed ID: 10023311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer in Morocco: epidemiological profile from two main oncological centers.
    Berraho M; Bendahhou K; Obtel M; Zidouh A; Benider A; Errihani H; Nejjari C
    Asian Pac J Cancer Prev; 2012; 13(7):3153-7. PubMed ID: 22994726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.